c. 2023. Awarded for: Differentiation-focused CRISPR Screen identifies LSD1 and Menin as combination therapy targets that induce terminal differentiation in AML. Congratulations Maria!!
c. 2023. Awarded for: Differentiation-focused CRISPR Screen identifies LSD1 and Menin as combination therapy targets that induce terminal differentiation in AML. Congratulations Maria!!